NCT06315010
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06315010
Title REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis (REPOSE)
Acronym REPOSE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | AUT

Facility Status City State Zip Country Details
Medizinische Universität Graz RECRUITING Graz 8010 Austria Details
Medical University of Vienna RECRUITING Vienna Austria Details
Hospital de Vinalopó RECRUITING Elche Alicante 03293 Spain Details
Hospital Universitari Sant Joan de Reus RECRUITING Reus Tarragona 43204 Spain Details
Hospital General Universitario Dr. Balmis RECRUITING Alicante 03010 Spain Details
Hospital de Cruces RECRUITING Barakaldo 48903 Spain Details
UOMI Cancer Center RECRUITING Barcelona 08017 Spain Details
Hospital Universitari Vall d'Hebron RECRUITING Barcelona 08035 Spain Details
Hospital Universitario de León RECRUITING León 24008 Spain Details
Hospital Beata María Ana RECRUITING Madrid 28007 Spain Details
Complejo Hospitalario Universitario de Santiago (CHUS) RECRUITING Santiago de Compostela 15706 Spain Details
Hospital Clínico Universitario de Valencia RECRUITING Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field